|

Glucagon-like peptide-1 receptor agonist：Semaglutide Clinical Trials

1 actively recruiting trial

Also known as: Semaglutide

Pipeline

Phase 4: 1

Top Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1

Indications

  • Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)1
  • Heart Disease1
  • Diabetes1
  • Type 2 Diabetes1

Other1 trial

The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.